GW Technology Commercialization Office

https://www.linkedin.com/company/gwutco We are focusing our social media announcements on LinkedIn. Please follow our new LinkedIn page for news about technologies created at GW, startups developing them, and events of topical interest.

Technology Commercialization Office of the George Washington University | LinkedIn Technology Commercialization Office of the George Washington University | From the lab to the world. GW TCO bridges the divide between the university and companies that impact the world. | The George Washington University (GW) Technology Commercialization Office (TCO), promotes and facilitates the t...

We invite the GW community to participate in an upcoming event, co-hosted by the TCO and the Society of Physician Entrepreneurs. Apply by March 5th to pitch your startup to a panel of investors via webinar, and receive coaching from a leadership communications expert prior to the event. You could learn the art of presenting to VCs firsthand! Four startups will be selected to present. Apply today, or just register to watch the webinar on March 24th. Two opportunities to learn! More details at

Pitch Perfect II: In Action! Pitch Perfect II: In Action brings the opportunity for you to meet with a panel of VCs, a 1:1 session with a leadership coach, and more!

We're excited for GW-invented drug, Giapreza, to start helping many critically ill patients with septic shock in Europe due to LJPC's sublicense to Paion. More on the news: La Jolla Pharmaceutical Company Announces Exclusive Licensing Agreement for GIAPREZA™ (Angiotensin II) and XERAVA™ (Eravacycline) in Europe - https://yhoo.it/3ibBr0R

Join our Sr. Licensing Manager, Brian Coblitz, for a webinar co-hosted by the Society of Physician Entrepreneurs on December 16, 2020. The experienced panel will discuss how startups should communicate with investors. Register on Eventbrite. https://go.gwu.edu/gwsope2020

Check out the video from our Sept 29th DC Startup Showcase. Featuring 10 minute pitches from 6 Biohealth startups from GW and Georgetown.

DC Startup Showcase @ GW This event has now ended. It was live on September 29, 2020. To view event recording please visit: https://youtu.be/OUrYxhayGwM or advance to 14:54 for conte...

GW Technology Commercialization Office brought a life-saving drug to market in record-breaking time!
Read the full Washington Business Journal Article

George Washington University, Barings strike 8-figure deal for Giapreza - Washington Business Journal George Washington University just sold a portion of its royalty rights to a drug developed its school of medicine, scoring a game-changing cash infusion it plans to reinvest in research and commercialization.

Join the GW TCO on April 16th from 1pm - 5:30pm in the GW Science and Engineering Hall for our 2019 Innovation Competition. The Competition will showcase impactful research with commercial potential and connect researchers, entrepreneurs and the venture community. Registration is free and all are welcome to attend!

TCO 2019 Innovation Competition The George Washington University and the Technology Commercialization Office are pleased to invite you to the 2019 Innovation Competition! The Technology Commercialization Office (TCO) is showcasing promising and impactful GW research with commercial potential. This event provides a forum for idea s...

Join GW TCO on 4/17 for our first Startup Showcase! 4 GW will present on their progress. 7 guests can provide a 2-minute pitch of their company or research projects during the session!

TCO 2018 Startup Showcase The George Washington University (GW) Technology Commercialization Office (TCO) is pleased to invite you to our inaugural 2018 Startup Showcase! Join GW TCO and our startup partners to hear their success stories and learn about their commercialization trajectory. This pitch event will showcase four....

Thanks to everyone that came out for another successful Bootcamp! Special thanks to Wilson Sonsini Goodrich & Rosati corporate and attorneys for putting on an informative program!

Congratulations to GW licensee, La Jolla Pharmaceutical Company, for the U.S. approval of its new drug Giapreza for adults with dangerously low blood pressure! https://goo.gl/EfZFBB

New Tech Brief 3min video: MiniHearts for Venous Insufficiency. Seeking commercialization partner to get into animal studies. Hearts in your legs! Inventor: Professor Narine Sarvazyan https://youtu.be/qQgdvgWF4h0

GW's MiniHearts for Venous Insufficiency 3min Movie GW researchers are developing a bioengineered Mini-Heart device to treat chronic deep venous insufficiency. The Mini-Heart is a rhythmic cuff made of cardiac...

GW licensee, La Jolla Pharmaceutical Company, announced that the U.S. accepted its New Drug Application for the investigational drug LJPC-50.

La Jolla Pharmaceutical Company Announces U.S. FDA Acceptance of New Drug Application for LJPC-501 La Jolla Pharmaceutical Company today announced that the U.S. Food and Drug Administration has accepted for review the Company’s New Drug Application for the investigational drug LJPC-501 for the treatment of hypotension in adults with distributive or vasodilatory shock who remain hypotensive despit...